2022 Symposium on the Current Management of Thyroid Nodules and Thyroid Cancer
Conference Overview
Inova Schar Cancer Institute presents:
2022 Symposium on the Current Management of Thyroid Nodules and Thyroid Cancer
The ISCI Endocrine Tumor Program presents a half-day symposium on the current management of benign, indeterminate and malignant thyroid nodules. This half-day course will provide practical tips and new knowledge about thyroid care for patients, including interpretation of diagnostic studies for thyroid nodules, emerging technologies in thyroid surgery, and treatment of thyroid cancer. Primary care providers, hospitalists, medical specialists, surgeons, advanced practice providers, researchers, and students all are invited to attend.
Program Directors
Samantha Diamond-Rossi, MD
Endocrinologist, ISCI Endocrine Tumor Program
Assistant Professor of Medical Education, University of Virginia
Jina Kim, MD
Endocrine Surgeon, ISCI Endocrine Tumor Program
William J. Purkert, MD
Director, ISCI Endocrine Tumor Program
Inova System Section Chief of Endocrine Surgery
Learning Objectives
1. Improve their understanding of the diagnostic paradigm for thyroid nodules
2. Learn about the range of surgical options for thyroid nodules and thyroid cancer available to patients
3. Describe the medical management and long-term surveillance of thyroid cancer
Accreditation
Inova CME Accreditation
The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.
Credit Designation
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 3.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 3.5 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.